Novo Nordisk begins selling new insulin pen in U.K.

Novo Nordisk ($NVO), one of the world's largest insulin providers, said that the company has brought its new disposable, prefilled insulin pen called FlexTouch to market in the U.K., providing diabetics there with a new method of delivering its fast-acting insulin analogue, NovoRapid. The disposable pen, which has a push-button system, appears to be designed to make it easy for patients to get very specific doses of insulin. One of the big problems in diabetes treatment is poor blood sugar control among patients, and major players in the industry such as Novo Nordisk, Eli Lilly ($LLY) and Sanofi ($SNY) have developed insulin pens and expanded the options patients have to get insulin doses to combat their disease. Release

Suggested Articles

J&J figures its partner Genmab owes a share of Darzalex Faspro royalties to Halozyme for its subcutaneous delivery tech. Genmab doesn't agree.

Bexson Biomedical and Stevanato Group teamed up to develop a ketamine pump that may help patients better manage pain at home.

Australia's University of New South Wales and Uka Tarsadia University in India will join forces to explore contact lenses for ocular drug delivery.